Modified factor VIII
AssigneeEmory University
InventorJohn S. Lollar
Life of this patent
Estimating the term…
Abstract
Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.
Claims2
An isolated and purified B-domainless porcine factor VIII comprising the sequence of SEQ ID NO:
- 39.
An isolated and purified B-domainless porcine factor VIII comprising the amino acid sequence of amino acids 20-1443 of SEQ ID NO:39.
Dependencies are inferred from the claim text.